Correction to “S-Enantiomer of the Antitubercular Compound S006

This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

Addition/Correction Cite This: ACS Omega 2017, 2, 9287−9287

Correction to “S-Enantiomer of the Antitubercular Compound S006830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope” Padam Singh, Shashi Kant Kumar, Vineet Kumar Maurya, Basant Kumar Mehta, Hafsa Ahmad, Anil Kumar Dwivedi, Vinita Chaturvedi,* Tejender S. Thakur,* and Sudhir Sinha* ACS Omega 2017, 2 (11), 8453−8465. DOI: 10.1021/acsomega.7b01281 orrection to page 8463. Under the Headings “Molecular Docking” and “Accession Codes”: The text (PDB ID: 3VIU) should be read as (PDB ID: 3V1U).

C

Received: December 10, 2017 Published: December 29, 2017 © 2017 American Chemical Society

9287

DOI: 10.1021/acsomega.7b01966 ACS Omega 2017, 2, 9287−9287